Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aemetis (AMTX) Other Non-Current Liabilities (2019 - 2025)

Aemetis (AMTX) has 7 years of Other Non-Current Liabilities data on record, last reported at $4.8 million in Q3 2025.

  • For Q3 2025, Other Non-Current Liabilities fell 8.1% year-over-year to $4.8 million; the TTM value through Sep 2025 reached $4.8 million, down 8.1%, while the annual FY2024 figure was $5.1 million, 0.59% up from the prior year.
  • Other Non-Current Liabilities reached $4.8 million in Q3 2025 per AMTX's latest filing, down from $4.8 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $6.0 million in Q2 2023 and bottomed at $2.3 million in Q1 2022.
  • Average Other Non-Current Liabilities over 5 years is $4.4 million, with a median of $4.8 million recorded in 2025.
  • Peak YoY movement for Other Non-Current Liabilities: tumbled 61.14% in 2021, then skyrocketed 127.28% in 2023.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $2.5 million in 2021, then skyrocketed by 123.19% to $5.5 million in 2022, then fell by 6.66% to $5.1 million in 2023, then rose by 0.59% to $5.1 million in 2024, then dropped by 6.5% to $4.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $4.8 million in Q3 2025, $4.8 million in Q2 2025, and $5.1 million in Q1 2025.